人工智能医疗科技领域的先驱Carlsmed近日宣布，成功完成了由B Capital和US Venture Partners共同领投的5250万美元C轮融资。这一资金注入将极大地推动该公司在医疗科技领域的创新步伐，特别是其在个性化手术领域的研发工作。
Carlsmed的核心产品aprevo ®个性化脊柱手术平台，专注于腰椎融合手术，将从这笔融资中受益，加速其商业化进程。aprevo ®平台利用人工智能技术，为医生提供精准的手术规划，以提高手术效果并减少患者康复时间。随着新资金的到位，Carlsmed将进一步强化其在脊柱手术市场的领先地位。
此外，公司还透露，计划利用部分融资开发适用于颈椎融合手术的新版aprevo ®平台，预计将于2025年正式推出。这一举措预示着Carlsmed在扩展其个性化手术解决方案的覆盖范围方面迈出了重要一步，旨在为更多患者提供更精准、更安全的治疗选择。
Carlsmed的这一轮融资不仅彰显了投资者对其技术潜力和市场前景的信心，也标志着人工智能在医疗手术领域应用的深化。随着科技与医疗的深度融合，Carlsmed有望引领行业变革，为全球患者带来更加先进、个性化的医疗服务。
英语如下：
**News Title:** “Carlsmed Raises $52.5 Million in Series C Funding, Accelerating the Growth of Its Personalized Surgery Platform, aprevo®”
**Keywords:** Carlsmed, Artificial Intelligence, Surgery Platform
**News Content:**
Carlsmed, a pioneer in artificial intelligence (AI) medical technology, has recently announced the successful completion of a $52.5 million Series C funding round led by B Capital and US Venture Partners. This injection of capital will significantly boost the company’s innovation in the medical technology sector, particularly in its efforts to develop personalized surgery.
The core product, aprevo®, a personalized spinal surgery platform focusing on lumbar fusion surgeries, will benefit from this funding, expediting its commercialization. The aprevo® platform, leveraging AI, enables surgeons to plan procedures with precision, enhancing surgical outcomes and reducing patients’ recovery time. With the new funds, Carlsmed aims to solidify its leadership position in the spinal surgery market.
Additionally, the company disclosed plans to invest part of the funding in developing an updated version of aprevo® for cervical fusion surgeries, expected to be launched in 2025. This move signifies a significant stride in expanding the scope of Carlsmed’s personalized surgical solutions, offering more precise and safer treatment options to a broader patient base.
This round of financing underscores investors’ confidence in Carlsmed’s technological potential and market prospects, as well as the growing integration of AI in medical surgeries. As technology and healthcare converge, Carlsmed is poised to drive industry transformation, delivering advanced and personalized healthcare services to patients worldwide.
【来源】https://www.businesswire.com/news/home/20240318820510/en/Carlsmed-Raises-52.5M-in-Series-C-Financing-to-Advance-Personalized-Spine-Surgery
Views: 1